We hypothesized that the immunohistochemical expression of MUC5AC and MUC5B in human large airways would differ among never-smokers, smokers, and COPD patients and that this may also be reflected by alterations in secreted MUC5AC and MUC5B concentrations. Here, MUC5B is linked to chronic obstructive pulmonary disease.